Clinical Trials Logo

Jaundice clinical trials

View clinical trials related to Jaundice.

Filter by:

NCT ID: NCT04182555 Completed - Jaundice, Neonatal Clinical Trials

Identification of Jaundice in Newborns Using Smartphones

Start date: August 3, 2020
Phase: N/A
Study type: Interventional

Neonatal jaundice is a common and most often harmless condition. However, when unrecognized it can be fatal or cause serious brain injury. Three quarters of these deaths are estimated to occur in the poorest regions of the world. The treatment of jaundice, phototherapy, is in most cases easy, low-cost and harmless. The crucial point in reducing the burden of disease is therefore to identify then children at risk. This results in the need for low-cost, reliable and easy-to-use diagnostic tools that can identify newborns with jaundice. Based on previous research on the bio-optics of jaundiced newborn skin, a prototype of a smartphone application was developed and tested in a pilot study and the application refined. This smartphone application will now be evaluated in a clinical trial set in two hospitals in Norway. The smartphone application gives immediate estimates of bilirubin values in newborns, and these estimates will be compared to the bilirubin levels measured in standard blood samples, as well as the results from ordinary transcutaneous measurement devices.

NCT ID: NCT04109859 Enrolling by invitation - Jaundice Clinical Trials

Effect of Methylene Blue on Perioperative Organ Function in Patients With Obstructive Jaundice

Start date: April 1, 2019
Phase: Phase 1
Study type: Interventional

Increased production of vasodilating substances such as NO plays an important role in the development of vasoplegic syndrome caused by obstructive jaundice.Methylene blue plays a role in raising blood pressure by inhibiting the vasodilator Nitric Oxide (NO)

NCT ID: NCT04099602 Completed - Neonatal Jaundice Clinical Trials

The Effect of Massage on Bilirubin Level in Infants

Start date: April 6, 2018
Phase: N/A
Study type: Interventional

Jaundice (hyperbilirubinemia) which is one of the common causes of repeated hospitalizations in the neonatal period, is a physiological condition seen in 60% of term babies and 80% of premature babies in the first week of life . Premature babies are more susceptible tobilirubin neurotoxicity. Death and severe sequelae due to hyperbilirubinemia can be prevented by early diagnosis and treatment. Massage is one of the applications that can be used to reduce bilirubin levels in newborn infants. Baby massage facilitates bowel movements and bilirubin excretion by reducing enterohepatic circulation. This study was designed as a randomized controlled trial to investigate the effect of massage on bilirubin levels in premature infants.

NCT ID: NCT04021927 Withdrawn - Jaundice, Neonatal Clinical Trials

Development of a Neonatal Jaundice Treatment Accelerator by Redirection of Unused Light During Phototherapy

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

This is a descriptive prospective study of safety and efficacy of the reflective PT ring device. Neonates with an elevated total serum bilirubin (TSB) meeting PT criteria per their clinician during hospital admission will be eligible for enrollment after informed parental consent.

NCT ID: NCT03977779 Recruiting - Biliary Stricture Clinical Trials

Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis

ARCHIMEDE
Start date: January 20, 2022
Phase: N/A
Study type: Interventional

The use of an endoprothesis in a pancreatic duct is a measure to minimize the incidence and severity of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis. In this study we will evaluate the use of a Biodegradable Endoprothesis: Archimede Fast Biodegradable Pancreatic Stent in patients with high risk of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis.The ARCHIMEDES Fast biodegradable pancreatic stent will be placed during the Endoscopic Retrograde CholoangioPancreatography. The efficacy and the security of the device will be evaluated.

NCT ID: NCT03942757 Completed - Preterm Infant Clinical Trials

BiLirubin Decrease Under Phototherapy Exposure in the Preterm Newborn in Incubator

BLUE
Start date: May 2, 2019
Phase:
Study type: Observational [Patient Registry]

Phototherapy is routinely used in neonatal intensive care units for the treatment of jaundice. Guidelines focus mainly on bilirubin serum levels to start the phototherapy. Only few data are available about clinical management of phototherapy devices and subsequently the impact on bilirubin serum decrease. Especially there are no strong recommendations about phototherapy duration, irradiance measurements, incubator temperature and humidity settings. Various factors can influence irradiance and thus the preterm infant bilirubin serum decrease. This study aims at evaluating the impact of an educational program on the use and efficacy of phototherapy in a neonatal intensive care unit.

NCT ID: NCT03933423 Recruiting - Neonatal Jaundice Clinical Trials

Home Based Phototherapy for Neonatal Jaundice

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

The main purpose of the study is to deliver community health worker based prevention, early screening and management of neonatal Jaundice using battery powered LED phototherapy device at the household level.

NCT ID: NCT03866213 Recruiting - Jaundice, Neonatal Clinical Trials

Validation of a Jaundice Diagnostic and Monitoring Device for Low-Resource Settings

Start date: August 1, 2019
Phase:
Study type: Observational

A team of researchers at Rice University in partnership with clinicians at Queen Elizabeth Central Hospital created BiliSpec, a low-cost battery-powered reader designed to immediately quantify serum bilirubin levels from a small drop of whole blood applied to a lateral flow strip. The simple and affordable BiliSpec system offers a faster and more cost-effective means to detect neonatal jaundice in under-resourced clinics and determine when phototherapy is needed. The goal of this study is to validate the accuracy of the BiliSpec device in measuring bilirubin levels in neonates relative to the laboratory spectrophotometric bilirubinometer and transcutaneous bilirubinometer measurements.

NCT ID: NCT03820544 Terminated - Pancreatic Cancer Clinical Trials

SEMS Placement Before Surgery in Unblocking Bile Duct in Patients With Periampullary Pancreatic Cancer With Severe Obstructive Jaundice

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

This trial studies the side effects of self expanding metal stent (SEMS) placement before surgery in unblocking the bile duct in patients with periampullary pancreatic cancer with severe obstructive jaundice. SEMS placement unblocks the bile duct and may help in improving bile drainage prior to surgery in patients with periampullary pancreatic cancer with severe obstructive jaundice.

NCT ID: NCT03805165 Enrolling by invitation - Jaundice, Neonatal Clinical Trials

Hour-specific Transcutaneous Bilirubin in Healthy Term and Near-term Newborns of China

Start date: February 1, 2019
Phase:
Study type: Observational

Make a neonatal jaundiced nomogram on Chinese jaundice data by joinning the major neonate centers all around China.